-
-
Safety,Quality,Efficacy -
Safety,Quality,Efficacy -
Safety,Quality,Efficacy
Provide users with high-quality blood products
.jpg)
About RAAS
Being vital for life saving, blood products are important national strategic reserve materials. Founded in 1988 and situated at No. 2009 Wangyuan Road, Fengxian District, Shanghai with a registered capital of RMB 6,740,787,907.00, Shanghai RAAS was listed on the Shenzhen Stock Exchange in June 2008 as a leading domestic blood products company that integrates source plasma collection, blood products research and development, production and sales.
-
36 years Extensive industry experience
-
5 units Production Bases
-
44 centers Plasma Donation Center
+0.20 (+3.13%)
RAAS Plasma Donation Center
As of Dec 2023, Shanghai RAAS and its subsidiaries had 44 plasma donation centers (including newly approved ) in China including those under construction, of which 18 are Shanghai RAAS , 19 are Tonrol Biopharmaceutical, 2 are Zhengzhou RAAS,3 are Zhejiang Haikang Biopharmaceutical and 2 are GuangXi RAAS, covering 11 provinces (autonomous regions) in Guangxi, Hunan, Hainan, Shaanxi, Anhui, Guangdong, Inner Mongolia, Zhejiang, Hubei, Jiangxi and Shandong.
-
18 centers Shanghai RAAS (including one subcenter)
-
19 centers Tonrol Biopharmaceutical
-
2 centers Zhengzhou RAAS
-
3 centers Zhejiang Haikang Biopharmaceutical
-
2 centers GuangXi RAAS
